Cargando…

Antibody Therapies for Large B-Cell Lymphoma

Large B-cell lymphomas (LBCLs) constitute a subgroup of aggressive but highly curable lymphoproliferative diseases. Treatment of relapsed/refractory (R/R) patients still represents an unmet clinical need, and novel drugs and combinations are in continuous development. The pan–B cell panel of surface...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novo, Mattia, Santambrogio, Elisa, Frascione, Pio Manlio Mirko, Rota-Scalabrini, Delia, Vitolo, Umberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141264/ https://www.ncbi.nlm.nih.gov/pubmed/34040344 http://dx.doi.org/10.2147/BTT.S281618

Ejemplares similares

Large B-cell lymphomas
por: Vitolo, Umberto
Publicado: (2019)

Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)

Intensified therapy in diffuse large B-cell lymphoma
por: Novo, Mattia, et al.
Publicado: (2017)

Follicular Lymphoma: The Management of Elderly Patient
por: Castellino, Alessia, et al.
Publicado: (2017)

Melanoma Brain Metastases in the Era of Target Therapies: An Overview
por: Becco, Paolo, et al.
Publicado: (2020)

Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?
por: Chiappella, Annalisa, et al.
Publicado: (2019)

Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
por: Carnevale-Schianca, Fabrizio, et al.
Publicado: (2021)

Development of combinatorial antibody therapies for diffuse large B cell lymphoma
por: Geanes, Eric S., et al.
Publicado: (2022)

Application of the Euro Clonality next‐generation sequencing‐based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial
por: Genuardi, Elisa, et al.
Publicado: (2021)

ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma
por: Nowakowski, Grzegorz S, et al.
Publicado: (2016)

Antibody Therapy of Pediatric B-Cell Lymphoma
por: Meyer-Wentrup, Friederike, et al.
Publicado: (2013)

T-Cell Engaging Antibodies in Diffuse Large B Cell Lymphoma—An Update
por: Balendran, Shalini, et al.
Publicado: (2023)

Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma
por: Rampotas, Alexandros, et al.
Publicado: (2021)

CAR T-Cell Therapy for Large B-Cell Lymphoma
por: Alencar, Maritza C.
Publicado: (2019)

CAR-T Cell Therapy in Large B Cell Lymphoma
por: Testa, Ugo, et al.
Publicado: (2023)

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series
por: Longo, Bianca Maria, et al.
Publicado: (2023)

A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
por: Sehn, Laurie H., et al.
Publicado: (2020)

Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin’s lymphoma: a case report and review of the literature
por: Rota Scalabrini, Delia, et al.
Publicado: (2014)

Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
por: Rossi, Alessandra, et al.
Publicado: (2021)

Antinuclear Antibodies Are Associated with an Increased Risk of Diffuse Large B-Cell Lymphoma
por: Frost, Eleanor, et al.
Publicado: (2023)

Heart of Lymphoma: Primary Mediastinal Large B-Cell Lymphoma with Endomyocardial Involvement
por: Rogowitz, Elisa, et al.
Publicado: (2013)

Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study
por: Bolen, Christopher R., et al.
Publicado: (2019)

Immune targeted therapy for diffuse large B cell lymphoma
por: Zheng, Yaxin, et al.
Publicado: (2021)

Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study
por: Kostakoglu, Lale, et al.
Publicado: (2021)

B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma
por: Mohammadnezhad, Leila, et al.
Publicado: (2023)

Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
por: Papageorgiou, Sotirios G., et al.
Publicado: (2022)

The antibody-drug conjugate loncastuximab tesirine for the treatment of diffuse large B-cell lymphoma
por: Calabretta, Eleonora, et al.
Publicado: (2022)

Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Harris, Leonard Jeff, et al.
Publicado: (2020)

Diffuse large B-cell lymphoma: new targets and novel therapies
por: Cheson, Bruce D., et al.
Publicado: (2021)

Evolution of therapy for limited stage diffuse large B-cell lymphoma
por: Rojek, Alexandra E., et al.
Publicado: (2022)

PB2132: COPANLISIB PLUS RITUXIMAB-BENDAMUSTINE FOR RELAPSED-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RECRUITMENT UPDATE ON AN ONGOING PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI (FIL_COPA-RB)
por: Novo, M., et al.
Publicado: (2022)

Intravascular Large B-Cell Lymphoma
por: Loukhnati, Mehdi, et al.
Publicado: (2023)

CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope
por: Hopfinger, Georg, et al.
Publicado: (2019)

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
por: Zurko, Joanna, et al.
Publicado: (2022)

Role of Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the CART Era
por: González Barca, Eva
Publicado: (2022)

Systematic review of therapy used in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma
por: Galaznik, Aaron, et al.
Publicado: (2018)

A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2022)

P1171: CNS RELAPSE OF DIFFUSE LARGE B-CELL LYMPHOMA. CLINICAL PRESENTATION, OUTCOME AND ROLE OF UPFRONT PROPHYLAXIS: A 10-YEAR SINGLE CENTER EXPERIENCE.
por: Benevolo Savelli, Corrado, et al.
Publicado: (2023)

SUN-475 Thyroid Extranodal Diffuse Large B-Cell Lymphoma in Setting of Gastric Large B-Cell Lymphoma
por: Russell, Yan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_49d56381u6eomgg8skf2kni85v